Cargando…
Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial
We evaluated the prognostic and predictive value of a range of molecular changes in the setting of a randomised trial comparing standard PCV (procarbazine, CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea) and vincristine) chemotherapy with the standard temozolomide (TMZ) 5-day (200 mg/m(2)/day) s...
Autores principales: | Collins, Vincent Peter, Ichimura, Koichi, Di, Ying, Pearson, Danita, Chan, Ray, Thompson, Lindsay C, Gabe, Rhian, Brada, Michael, Stenning, Sally P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229733/ https://www.ncbi.nlm.nih.gov/pubmed/24952577 http://dx.doi.org/10.1186/2051-5960-2-68 |
Ejemplares similares
-
Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma.
por: Brada, M., et al.
Publicado: (1995) -
Back to the future--radiotherapy in high grade gliomas.
por: Brada, M.
Publicado: (1989) -
Radiotherapy in high grade gliomas
por: Bleehen, N.M., et al.
Publicado: (1989) -
A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)
por: Huddart, Robert A., et al.
Publicado: (2015) -
An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma.
por: Stenning, S. P., et al.
Publicado: (1987)